IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.260
-0.120 (-5.04%)
At close: Jun 13, 2025, 4:00 PM
2.270
+0.010 (0.44%)
After-hours: Jun 13, 2025, 7:50 PM EDT

IN8bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
819605782-
Upgrade
Market Cap Growth
-73.59%-68.76%5.43%-31.25%--
Upgrade
Enterprise Value
020523444-
Upgrade
Last Close Price
2.267.7241.4069.30131.70-
Upgrade
PB Ratio
0.441.292.392.492.16-
Upgrade
P/TBV Ratio
0.561.292.392.492.16-
Upgrade
Debt / Equity Ratio
0.310.350.200.260.060.01
Upgrade
Quick Ratio
4.023.613.953.1216.417.00
Upgrade
Current Ratio
4.304.084.573.8217.287.05
Upgrade
Return on Equity (ROE)
-174.66%-154.44%-125.90%-93.64%-51.87%-91.01%
Upgrade
Return on Assets (ROA)
-73.25%-67.70%-56.81%-47.37%-29.01%-48.53%
Upgrade
Return on Capital (ROIC)
-80.38%-74.99%-64.89%-51.52%-31.00%-56.36%
Upgrade
Earnings Yield
-352.33%-163.26%-50.29%-50.39%-17.80%-
Upgrade
FCF Yield
-250.10%-130.54%-40.12%-49.16%-16.78%-
Upgrade
Buyback Yield / Dilution
-84.32%-79.30%-42.43%-110.32%-191.59%-7.24%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q